Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novavax Gets FDA Approval To Resume Testing 2 Vaccines
FDA lifts pause on Novavax flu vaccine trials
After an investigation, the agency concluded that a case of muscle weakness in one of Novavax’s trials was actually ALS and unrelated to vaccination.
Novavax Gets FDA Approval To Resume Testing Two Vaccines After Clinical Hold
The company said further information supported its contention that the
vaccine
did not cause ... COVID-19-
flu
and standalone
flu
vaccines. The company explained that the U.S. Food and Drug Administration (
FDA
) removed its clinical hold on the studies ...
US FDA lifts clinical hold on Novavax's combo COVID-flu shot
The U.S. Food and Drug Administration has lifted its clinical hold on a late-stage trial of Novavax's COVID-influenza and its standalone flu vaccines after a safety concern was found to be unrelated to the combination shot,
Novavax to Move Forward With Covid-19-Flu Vaccine After FDA Lifts Clinical Hold -- Update
Novavax is already poised to benefit from a separate combined Covid-flu vaccine via a deal with Sanofi announed earlier this year. Under the $1.4 billion co-licensing agreement, announced in May, Sanofi will have the sole right to use Novavax's existing Covid-19 vaccine in combination with its own flu vaccine.
FDA Lifts Clinical Hold On Novavax COVID-19-Influenza Combo Vaccine Candidate; Stock Up
Monday said the Food and Drug Administration or FDA has removed the clinical hold on its COVID-19-Influenza Combination (CIC) and stand-alone influenza vaccine candidates. Novavax shares were up more than 13 percent in pre-market.
Novavax stock soars as FDA removes clinical hold on its COVID and influenza shot
The U.S. Food and Drug Administration (FDA) has lifted its hold on a late-stage trial for Novavax’s COVID-influenza combination and standalone flu vaccines, the company reported on Monday (NASDAQ:MNDY).
Novavax climbs as FDA lifts clinical hold on Covid, flu combo trials
Novavax (NVAX) shares surge 12% as FDA lifts clinical hold on COVID-19-Influenza Combination vaccine candidates.
The Union Democrat
2h
Mayo Clinic Minute: 3 misconceptions about COVID-19 and flu vaccines
"You aren't going to get the
flu
from the
flu
vaccine
. You're not going to get COVID from the ... are licensed or ...
STAT
6d
A Q&A with the FDA’s top vaccine regulator amid a fresh wave of disinformation
A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...
JD Supra
2d
FDA Approves the First Flu Vaccine for At Home Use, Providing a Needle Free Option Outside of Traditional Health Care Settings
On September 20, 2024, the U.S. Food and Drug Administration (FDA) approved the first influenza (flu) vaccine for at‑home use. The vaccine, ...
6h
Expert explains three misconceptions about COVID-19 and flu vaccines
Dr. Robert Jacobson, medical director for Mayo Clinic's Primary Care Immunization Program, clears up some misconceptions about COVID-19 and the flu.
2h
The RSV Vaccine for Infants: Everything Parents Need to Know
The other group at the highest risk when it comes to RSV is children under age five, and specifically infants—especially ...
3d
on MSN
“Pack your bags” RFK Jr. tells FDA. His war on public health under Trump would only accelerate
In an interview with NPR on Wednesday, Kennedy said Trump had already assigned him three tasks: to reduce the “corruption and ...
4d
Moderna reports surprise profit on higher-than-expected COVID vaccine sales
Moderna reported a surprise third-quarter profit on Thursday, driven by cost cutting and higher-than-expected sales of its ...
WBAL-TV
19h
Medical Alert: Concerns about walking pneumonia this cold and flu season
DALENCIA AND THIS MORNING’S MEDICAL ALERT AS WE ENTER COLD AND
FLU
SEASON, DOCTORS ARE STARTING TO SEE A RISE ... BUT THEN ...
devdiscourse
1d
Global Health Updates: Pharma Tariffs, RSV Vaccine Approval, and Infant Formula Insights
Recent health news highlights include Recordati's nonchalance towards potential U.S. tariffs, Canada's approval of Moderna's ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback